PARP inhibitors in primary and recurrent ovarian cancer
E-session 508
/
CME accredited
Expert:
Mansoor Raza Mirza
Rigshospitalet
Copenhagen, Denmark
Discussant:
Mikkel Rosendahl
Rigshospitalet, Copenhagen, Denmark
The live session starts in about 4 days
Access to the live session will open 10 minutes before the start of the session
This session is part of the following pathway(s):
GYNAECOLOGY: Ovarian cancerIn order to access to the CME test, please check the minimum system requirements.
If the WebEx platform is used in temporary mode, access to the CME test can not be guaranteed
Check the minimum system requirements
12
Dec 2019
18:15-19:00 CET